| |
Combulin™
| Primary Indication |
Treatment of Type 2 diabetes
mellitus |
| Stage of Development |
Preclinical |
- As a follow-on product to
Capsulin, Diabteology is developing an oral
combination therapy bringing insulin and
insulin sensitizing agents together
- Therapeutic benefit from
simultaneous dosing of insulin and insulin
sensitizer
|
|
|
